A new paradigm of mechanism- and patient-centered pharmaceutical research and development

New Mechanism, New Target Drug Pipelines

  • Pancreatic cancer
    Small molecules
    ZY0001
  • Pan-cancer
    Biologics
    ZY0002
  • Pancreatic cancer
    Small molecules
    ZY0003

Drug Repurposing Pipelines

  • CDK4/6 inhibitors
    ZYNI001
  • PARP inhibitors
    ZYNI002
  • Anti-tumor drugs
    ZYNI003
    Undisclosed
  • Anti-tumor drugs
    ZYNI004
    Undisclosed
  • Anti-tumor drugs
    ZYNI005
    Undisclosed

Precision Medical Products Pipelines

  • Liver cancer
    Companion diagnostics
  • Breast cancer
    Precision pathological classification
  • Breast cancer
    Very early accurate diagnosis

Clinical Research Programs

  • Breast cancer
    Study on the pathogenesis of triple negative breast cancer based on germline genome
  • Liver cancer
    Establish the applicability method of HAI-FOLFOX in patients with liver cancer
  • Breast cancer
    Study on germline genomic etiology and early prevention of breast cancer
  • Pansolid tumor
    Clinical research on drug repurposing and companion diagnostics
  • Lung cancer
    Study the mechanism of brain metastasis of lung adenocarcinoma
  • Solid tumor
    Study the precise distribution mechanism of targeted drugs
  • Solid tumor
    Study the precise distribution mechanism of targeted drugs

扫一扫关注公众号